X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with ALEMBIC LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs ALEMBIC LTD - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE ALEMBIC LTD CADILA HEALTHCARE/
ALEMBIC LTD
 
P/E (TTM) x 34.8 75.7 45.9% View Chart
P/BV x 9.0 2.8 318.6% View Chart
Dividend Yield % 0.7 0.4 171.2%  

Financials

 CADILA HEALTHCARE   ALEMBIC LTD
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-16
ALEMBIC LTD
Mar-16
CADILA HEALTHCARE/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs45453 860.6%   
Low Rs30529 1,039.2%   
Sales per share (Unadj.) Rs96.14.7 2,036.0%  
Earnings per share (Unadj.) Rs14.98.8 169.5%  
Cash flow per share (Unadj.) Rs17.89.0 198.0%  
Dividends per share (Unadj.) Rs3.200.15 2,133.3%  
Dividend yield (eoy) %0.80.4 230.8%  
Book value per share (Unadj.) Rs52.327.7 188.5%  
Shares outstanding (eoy) m1,023.74267.03 383.4%   
Bonus/Rights/Conversions FV5:1--  
Price / Sales ratio x3.98.7 45.4%   
Avg P/E ratio x25.54.7 545.3%  
P/CF ratio (eoy) x21.34.6 466.9%  
Price / Book Value ratio x7.31.5 490.3%  
Dividend payout %21.51.7 1,258.5%   
Avg Mkt Cap Rs m388,45810,962 3,543.8%   
No. of employees `00015.4NA-   
Total wages/salary Rs m13,317238 5,595.4%   
Avg. sales/employee Rs Th6,371.1NM-  
Avg. wages/employee Rs Th862.4NM-  
Avg. net profit/employee Rs Th986.1NM-  
INCOME DATA
Net Sales Rs m98,3761,260 7,805.8%  
Other income Rs m941264 356.7%   
Total revenues Rs m99,3171,524 6,516.4%   
Gross profit Rs m23,82983 28,779.0%  
Depreciation Rs m3,02261 4,921.8%   
Interest Rs m4860 162,000.0%   
Profit before tax Rs m21,262285 7,463.0%   
Minority Interest Rs m-3000-   
Prior Period Items Rs m52,096 0.2%   
Extraordinary Inc (Exp) Rs m-25-32 77.6%   
Tax Rs m5,7166 93,704.9%   
Profit after tax Rs m15,2262,343 649.9%  
Gross profit margin %24.26.6 368.7%  
Effective tax rate %26.92.1 1,255.6%   
Net profit margin %15.5185.9 8.3%  
BALANCE SHEET DATA
Current assets Rs m44,3761,689 2,627.7%   
Current liabilities Rs m34,071486 7,007.6%   
Net working cap to sales %10.595.4 11.0%  
Current ratio x1.33.5 37.5%  
Inventory Days Days54217 24.8%  
Debtors Days Days6281 76.9%  
Net fixed assets Rs m47,8961,624 2,949.1%   
Share capital Rs m1,024534 191.7%   
"Free" reserves Rs m48,7465,960 817.9%   
Net worth Rs m53,5197,404 722.8%   
Long term debt Rs m8,964104 8,594.4%   
Total assets Rs m100,1638,010 1,250.4%  
Interest coverage x44.7950.7 4.7%   
Debt to equity ratio x0.20 1,189.0%  
Sales to assets ratio x1.00.2 624.2%   
Return on assets %15.729.3 53.6%  
Return on equity %28.431.6 89.9%  
Return on capital %34.331.3 109.6%  
Exports to sales %45.32.9 1,537.9%   
Imports to sales %5.928.9 20.6%   
Exports (fob) Rs m44,53737 120,045.8%   
Imports (cif) Rs m5,838364 1,605.2%   
Fx inflow Rs m44,88137 120,973.0%   
Fx outflow Rs m9,069365 2,485.1%   
Net fx Rs m35,812-328 -10,923.6%   
CASH FLOW
From Operations Rs m19,938346 5,769.1%  
From Investments Rs m-9,039-48 18,989.5%  
From Financial Activity Rs m-9,527-301 3,165.1%  
Net Cashflow Rs m1,372-3 -45,733.3%  

Share Holding

Indian Promoters % 74.8 64.0 116.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 0.2 4,150.0%  
FIIs % 5.9 9.7 60.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 26.1 42.1%  
Shareholders   44,069 54,701 80.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  UNICHEM LAB  ALKEM LABORATORIES  AJANTA PHARMA  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Aug 22, 2017 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS